HEARING OF THE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS UNITED STATES SENATE ONE HUNDRED TENTH CONGRESS FIRST SESSION ON EXAMINING FOOD AND DRUG ADMINISTRATION…{/exp:chopper}'} Senate Committee Hearing 110-375, Examining FDA Follow-On Bi Skip to Content


Senate Committee on Health, Education, Labor, and Pensions

HEARING OF THE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS

UNITED STATES SENATE
ONE HUNDRED TENTH CONGRESS
FIRST SESSION

ON
EXAMINING FOOD AND DRUG ADMINISTRATION FOLLOW-ON BIOLOGICS, GENERALLY REFERRED TO AS A BIOTECHNOLOGY-DERIVED PROTEIN DRUG (OR BIOLOGIC) THAT IS COMPARABLE TO A NOVEL, PREVIOUSLY APPROVED BIOLOGIC AND THAT IS APPROVED WITH LESS SUPPORTING DATA THAN THE INNOVATOR BIOLOGIC

Download the Full Transcript

Tags

biotechnology   fda   health law policy   pharmaceuticals   regulation